HaploX specializes in genetic testing solutions, gene sequencing, liquid biopsy, bioinformatics, and big data analysis.
HaploX Global stands at the forefront of Biotechnology Research, offering cutting-edge genetic testing solutions, gene sequencing, liquid biopsy, bioinformatics, and big data analysis. Driven by a commitment to technological innovation, HaploX Global aims to harness advanced science for the betterment of humanity. Serving a diverse clientele, including hospitals, biopharmaceutical entities, scientific research institutions, and healthcare organizations, HaploX Global is a trusted expert in the field.
HaploX Global's laboratory adheres to stringent international best practice guidelines and is accredited by recognized bodies including the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the European Molecular Genetics Quality Network (EMQN). This ensures the highest standards of quality and reliability in their testing processes. With a comprehensive range of services encompassing clinical genetic testing, non-clinical testing solutions, and pharmaceutical drugs R&D, HaploX Global is dedicated to providing exceptional service and innovative solutions.
The primary address of HaploX Global is Unit 609-610, 6/F, Building 16W, Phase 3, Hong Kong Science Park, Pak Shek Kok, N.T., Hong Kong, Hong Kong, HK. HaploX Global is establishing itself as a preeminent life sciences company globally. We invite the manager of HaploX Global to create a customized and exclusive company showcase and product listing on our platform.
HaploX Global est à l'avant-garde de la recherche biotechnologique, offrant des solutions de pointe en matière de tests génétiques, de séquençage génétique, de biopsie liquide, de bio-informatique et d'analyse de données massives. Poussé par un engagement envers l'innovation technologique, HaploX Global vise à exploiter la science de pointe pour le bien de l'humanité. Au service d'une clientèle diversifiée, comprenant des hôpitaux, des entités biopharmaceutiques, des institutions de recherche scientifique et des organismes de santé, HaploX Global est un expert de confiance dans le domaine.
Le laboratoire de HaploX Global adhère à des directives internationales strictes de meilleures pratiques et est accrédité par des organismes reconnus, notamment le Collège américain des pathologistes (CAP), les amendements relatifs à l'amélioration des laboratoires cliniques (CLIA) et le Réseau européen de contrôle de la qualité de la génétique moléculaire (EMQN). Cela garantit les normes les plus élevées de qualité et de fiabilité dans leurs processus de test. Avec une gamme complète de services comprenant les tests génétiques cliniques, les solutions de tests non cliniques et la R&D de médicaments pharmaceutiques, HaploX Global se consacre à fournir un service exceptionnel et des solutions innovantes.
L'adresse principale de HaploX Global est Unit 609-610, 6/F, Building 16W, Phase 3, Hong Kong Science Park, Pak Shek Kok, N.T., Hong Kong, Hong Kong, HK. HaploX Global s'impose comme une société de sciences de la vie de premier plan à l'échelle mondiale. Nous invitons le responsable de HaploX Global à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Compare HaploX Global with 3 companies in Biotechnology-Research
| Comparison Field |
HaploX GlobalMain Company |
Rayca PrecisionView Profile |
Theragen BioView Profile |
PsomagenView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2022 | 2020 | 2012 |
|
Company Size
|
— | 11-50 | 51-200 | 51-200 |
|
City
|
Hong Kong, Hong Kong | San Francisco, CA | Seongnam-si, Gyeoggi-do | Rockville, Maryland |
|
Country
|
Hong Kong | United States | South Korea | United States |
|
Skills & Keywords
Comparing with main company
|
21 Total Skills
Genetic Testing Solutions
Gene Sequencing
Liquid Biopsy
Bioinformatics
Big Data Analysis
Pharmaceutical R&D
Clinical Genetic Testing
Multi-Omics
Pharmaceutical drugs R&D
Clinical Genetic Solutions
Big Data Analytics in Healthcare
MRD Detection
Epigenome
Transcriptome
Genomics
Precision medicine diagnostic solutions
Next-Generation Sequencing
Metabolome
Bioinformatics Solutions
Liquid Biopsies
Cancer Genetic Testing
|
13 Total
1 Common
12 Unique
Match
5%
Common Skills:
Bioinformatics
Unique Skills:
AI Drug Design
AI-based Clinical Trial
Clinical Genomics
Clinical Trial
Computational Biology
Computational Drug Design
+6
|
7 Total
1 Common
6 Unique
Match
5%
Common Skills:
Bioinformatics
Unique Skills:
Drug research
Genome
Healthcare
MiRNA
Personalized Genetic Analysis for Disease Risks
Sequencing
|
17 Total
17 Unique
Unique Skills:
Capillary Electrophoresis Sequencing
CES
Clinical Whole Exome Sequencing
Clinical Whole Genome Sequencing
COVID-19 Diagnostics Testing
COVID-19 Research
+11
|
Other organizations in the same industry
This company is also known as